Skip to main content
. 2020 May 10;25(9):2248. doi: 10.3390/molecules25092248

Figure 7.

Figure 7

The relationship between cell motility and MAPK inhibitors in human oral cancer cells following sesamin treatment. (a) HSC-3 and (c) FaDu cells were pretreated with SP600125 or SB203580 for 1 h and then incubated in the presence or absence of 40 μM SES for 24 -h. After that, wound-healing assays were performed at different time points. (b) HSC-3 cells shown at 2, 4, and 6 h, depicting the wound closure distances for quantitative analysis. (d) FaDu cells shown at 3, 6, and 24 h, depicting the wound closure distances for quantitative analysis. The values represent the means ± SD of at least three independent experiments. * p < 0.05, compared with the control group. # p < 0.05, compared with the SES-treated group.